Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1094073

Depression: Biological markers and treatment


Nedić Erjavec, Gordana; Šagud, Marina; Nikolac Perković, Matea; Švob Štrac, Dubravka; Konjevod, Marcela; Tudor, Lucija; Uzun, Sandra; Pivac, Nela
Depression: Biological markers and treatment // Progress in neuro-psychopharmacology & biological psychiatry, 105 (2021), 110139, 21 doi:10.1016/j.pnpbp.2020.110139 (međunarodna recenzija, pregledni rad, znanstveni)


CROSBI ID: 1094073 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Depression: Biological markers and treatment

Autori
Nedić Erjavec, Gordana ; Šagud, Marina ; Nikolac Perković, Matea ; Švob Štrac, Dubravka ; Konjevod, Marcela ; Tudor, Lucija ; Uzun, Sandra ; Pivac, Nela

Izvornik
Progress in neuro-psychopharmacology & biological psychiatry (0278-5846) 105 (2021); 110139, 21

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni

Ključne riječi
glycomics ; HPA axis ; immune markers ; metabolomics ; neurotransmitters ; treatment response

Sažetak
Nowadays depression is considered as a systemic illness with different biological mechanisms involved in its etiology, including inflammatory response, hypothalamic-pituitary- adrenal (HPA) axis dysregulation and neurotransmitter and neurotrophic systems imbalance. Novel "omics" approaches, such as metabolomics and glycomics provide information about altered metabolic pathways and metabolites, as well as disturbances in glycosylation processes affected by or causing the development of depression. The clinical diagnosis of depression continues to be established based on the presence of the specific symptoms, but due to its heterogeneous underlying biological background, that differs according to the disease stage, there is an unmet need for treatment response biomarkers which would facilitate the process of appropriate treatment selection. This paper provides an overview of the role of major stress response system, the HPA axis, and its dysregulation in depression, possible involvement of neurotrophins, especially brain- derived neurotrophic factor, glial cell line- derived neurotrophic factor and insulin-like growth factor-1, in the development of depression. Article discusses how activated inflammation processes and increased cytokine levels, as well as disturbed neurotransmitter systems can contribute to different stages of depression and could specific metabolomic and glycomic species be considered as potential biomarkers of depression. The second part of the paper includes the most recent findings about available medical treatment of depression. The described biological factors impose an optimistic conclusion that they could represent easy obtainable biomarkers potentially predicting more personalized treatment and diagnostic options.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA


Ustanove:
Institut "Ruđer Bošković", Zagreb,
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb

Poveznice na cjeloviti tekst rada:

doi www.sciencedirect.com doi.org

Citiraj ovu publikaciju:

Nedić Erjavec, Gordana; Šagud, Marina; Nikolac Perković, Matea; Švob Štrac, Dubravka; Konjevod, Marcela; Tudor, Lucija; Uzun, Sandra; Pivac, Nela
Depression: Biological markers and treatment // Progress in neuro-psychopharmacology & biological psychiatry, 105 (2021), 110139, 21 doi:10.1016/j.pnpbp.2020.110139 (međunarodna recenzija, pregledni rad, znanstveni)
Nedić Erjavec, G., Šagud, M., Nikolac Perković, M., Švob Štrac, D., Konjevod, M., Tudor, L., Uzun, S. & Pivac, N. (2021) Depression: Biological markers and treatment. Progress in neuro-psychopharmacology & biological psychiatry, 105, 110139, 21 doi:10.1016/j.pnpbp.2020.110139.
@article{article, author = {Nedi\'{c} Erjavec, Gordana and \v{S}agud, Marina and Nikolac Perkovi\'{c}, Matea and \v{S}vob \v{S}trac, Dubravka and Konjevod, Marcela and Tudor, Lucija and Uzun, Sandra and Pivac, Nela}, year = {2021}, pages = {21}, DOI = {10.1016/j.pnpbp.2020.110139}, chapter = {110139}, keywords = {glycomics, HPA axis, immune markers, metabolomics, neurotransmitters, treatment response}, journal = {Progress in neuro-psychopharmacology and biological psychiatry}, doi = {10.1016/j.pnpbp.2020.110139}, volume = {105}, issn = {0278-5846}, title = {Depression: Biological markers and treatment}, keyword = {glycomics, HPA axis, immune markers, metabolomics, neurotransmitters, treatment response}, chapternumber = {110139} }
@article{article, author = {Nedi\'{c} Erjavec, Gordana and \v{S}agud, Marina and Nikolac Perkovi\'{c}, Matea and \v{S}vob \v{S}trac, Dubravka and Konjevod, Marcela and Tudor, Lucija and Uzun, Sandra and Pivac, Nela}, year = {2021}, pages = {21}, DOI = {10.1016/j.pnpbp.2020.110139}, chapter = {110139}, keywords = {glycomics, HPA axis, immune markers, metabolomics, neurotransmitters, treatment response}, journal = {Progress in neuro-psychopharmacology and biological psychiatry}, doi = {10.1016/j.pnpbp.2020.110139}, volume = {105}, issn = {0278-5846}, title = {Depression: Biological markers and treatment}, keyword = {glycomics, HPA axis, immune markers, metabolomics, neurotransmitters, treatment response}, chapternumber = {110139} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font